Physician profile
David Delatte
NPI 1215226287
$7,630.63
in general payments reported to CMS, 2019-2025
21 companies · $878 in 2025
The $878 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,465 · 2020: $482 · 2021: $1,625 · 2022: $1,040 · 2023: $688 · 2024: $453 · 2025: $878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,019.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,544.44 | 2019-2025 | Proclaim, Eterna |
| Vertiflex, INC. | $1,336.35 | 2019 | |
| Boston Scientific Corporation | $898.10 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $797.43 | 2019-2020 | |
| Nalu Medical, INC. | $344.11 | 2021-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $147.55 | 2021-2023 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $133.11 | 2023 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $129.28 | 2020-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.47 | 2019-2020 | |
| Pfizer INC. | $39.70 | 2019-2025 | |
| Saluda Medical Americas, INC. | $38.75 | 2025 | Evoke |
| Almatica Pharma LLC | $27.21 | 2021 | |
| Lilly USA, LLC | $16.61 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $16.55 | 2025 | Cologuard Collection Kit |
| Flowonix Medical Incorporated | $16.08 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $15.48 | 2020 | |
| Valinor Pharma, LLC | $14.76 | 2023 | Movantik |
| Nevro Corp. | $14.58 | 2022 | |
| Daiichi Sankyo INC. | $14.45 | 2019 | |
| Shionogi INC | $12.93 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Delatte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.